Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Analysts predict Mounjaro to generate around US$ 8.1 billion in annual sales by 2028, while Wegovy is expected to bring in US$ 7 billion by 2030
While severe side effects, such as pancreatitis or thyroid cancer, are rare, it's important to consult with a healthcare provider before starting treatment, particularly for those with a history of these conditions
Shea, B
News from TRIUMPH-1, a Phase 3 trial of retatrutide, the first-in-class GIP/GLP-1/GCGR agonist investigating the effect of adding glucagon receptor activation on top of the dual mechanism of tirzepatide
Check product labeling for specific requirements
US$ 28.96
US$ 22.68
US$ 24.55
